Rocaglamide



Compound IDCDAMM00440
Common nameRocaglamide
IUPAC name1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-2-carboxamide
Molecular formulaC29H31NO7

Experimental data

Retention time0.31
Adduct[M+K]+
Actual mz544.179
Theoretical mz544.173
Error10.37
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.5401

Identifiers and class information

Inchi keyDAPAQENNNINUPW-AMVGUFJQNA-N
SmilesO=C(N(C)C)C1C(O)C2(O)C=3C(OC)=CC(OC)=CC3OC2(C4=CC=C(OC)C=C4)C1C=5C=CC=CC5
SuperclassOrganoheterocyclic compounds
ClassBenzofurans

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)505.566
Computed dipole moment(dipole)6.658
Total solvent accessible surface area (SASA)769.393
Hydrophobic component of SASA (FOSA)425.918
Hydrophilic component of SASA (FISA)70.487
Pie component of the SASA (PISA)272.988
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1476.49
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)7.45
Free energy of solvation of dipole (dip^2/V)0.0300222
Index of cohesive interaction in solids (ACxDN^.5/SA)0.009683
Globularity descriptor (glob)0.815025
Predicted polarizability in cubic angstroms (QPpolrz)51.69
Predicted hexadecane/gas partition coefficient (QPlogPC16)14.543
Predicted octanol/gas partition coefficient (QPlogPoct)22.931
Predicted water/gas partition coefficient (QPlogPw)12.956
Predicted octanol/water partition coefficient (QPlogPo/w)4.635
Predicted aqueous solubility (QPlogS)-5.784
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.983
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.453
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1440.9
Predicted brain/blood partition coefficient (QPlogBB)-0.506
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1117.66
Predicted skin permeability, log Kp (QPlogKp)-1.281
PM3 calculated ionization potential (IP(ev))9.134
PM3 calculated electron affinity (EA(eV))-0.076
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)0.57
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)21.211
Van der Waals surface area (PSA)87.216
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P08183ABCB1P-glycoprotein 1T25258SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P25101EDNRAEndothelin receptor ET-AT23499SEA
P16109SELPP-selectinT10965SEA
P24530EDNRBEndothelin receptor ET-BT92828SEA
P60842EIF4A1Eukaryotic initiation factor 4A-IT86805SEA
P47901AVPR1BVasopressin V1b receptorT59881SEA
Q7RTX1TAS1R1Taste receptorT41263SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T10965DI0088Circulatory system disease[ICD-11: BE2Z]P16109SELP
T10965DI0381Sickle-cell disorder[ICD-11: 3A51]P16109SELP
T92828DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P24530EDNRB
T92828DI0356Pulmonary hypertension[ICD-11: BB01]P24530EDNRB
T86805DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P60842EIF4A1
T59881DI0009Acute diabete complication[ICD-11: 5A2Y]P47901AVPR1B
T59881DI0041Autism spectrum disorder[ICD-11: 6A02]P47901AVPR1B
T59881DI0194Hypo-osmolality/hyponatraemia[ICD-11: 5C72]P47901AVPR1B
T41263DI0078Cholera[ICD-11: 1A00]Q7RTX1TAS1R1

Copyright © 2025